TherapeuticsMD Inc reports results for the quarter ended in March - Earnings Summary

TherapeuticsMD

06/05/2021 15:45

* TherapeuticsMD Inc  TXMD.OQ  reported a quarterly adjusted
loss of 11 cents​​ per share for the quarter ended in March. The
mean expectation of five analysts for the quarter was for a loss
of 12 cents per share.
* Revenue rose 62.2% to $19.87 million from a year ago​; 
analysts expected $19.77 million.
* TherapeuticsMD Inc's reported EPS for the quarter was a loss
of 11 cents​.
* The mean earnings estimate of analysts had fallen by
about 12.3% in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* TherapeuticsMD Inc shares had fallen by 4.5% this quarter and
gained 5.8% so far this year.
* The company reported a quarterly loss of $39.38 million.
* Wall Street's median 12-month price target for TherapeuticsMD
Inc is $5.50 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 6 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
This summary was machine generated May 6 at 02:45 p.m. GMT. ​All
figures in US Dollars.​